Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513. (Q27310843)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513. |
scientific article |
Statements
1 reference
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513. (English)
1 reference
David G Brachman
1 reference
Stephanie L Pugh
1 reference
Lynn S Ashby
1 reference
Theresa A Thomas
1 reference
Erin M Dunbar
1 reference
Samir Narayan
1 reference
H Ian Robins
1 reference
Joseph A Bovi
1 reference
Jason K Rockhill
1 reference
Minhee Won
1 reference
Walter P Curran
1 reference
1 April 2015
1 reference
91
1 reference
961-967
1 reference
Identifiers
1 reference
1 reference